Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Pharma Industry News VectivBio initiates phase 3 trial of apraglutide in patients with short bowel syndrome VectivBio, a leading Swiss biotechnology firm, has announced the commencement of patient dosing in its phase 3 STARS… bypharmanewsdailyFebruary 3, 2021